1. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022) Authors: Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;... Journal: Lancet Issue: Volume 399:Issue 10323(2022) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An Unusual Cause of Subacute Headache in a Patient Undergoing Chemotherapy for Advanced Testicular Nonseminomatous Germ Cell Tumour. (21st April 2016) Authors: Clarke, Helen M.; Rao, Ankit R.; Porfiri, Emilio Other Names: Palmirotta Raffaele Academic Editor. Journal: Case reports in oncological medicine Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC): can this lead to the adverse effect of hypogonadism?. Issue 6 (3rd June 2019) Authors: Afshar, Mehran; Patel, Hiten R. H.; Jain, Ankit; Kumar, Abhishek; Patel, Prashant; James, Nicholas D.; Porfiri, Emilio Journal: Expert review of anticancer therapy Issue: Volume 19:Issue 6(2019) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost‐effectiveness of zoledronic acid and strontium‐89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate‐refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747). (10th July 2016) Authors: Andronis, Lazaros; Goranitis, Ilias; Pirrie, Sarah; Pope, Ann; Barton, Darren; Collins, Stuart; Daunton, Adam; McLaren, Duncan; O'Sullivan, Joe M.; Parker, Chris; Porfiri, Emilio; Staffurth, John; Stanley, Andrew; Wylie, James; Beesley, Sharon; Birtle, Alison; Brown, Janet E.; Chakraborti, Prabir... Journal: BJU international Issue: Volume 119:Number 4(2017) Page Start: 522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette–Guérin. (June 2014) Authors: Liu, Xiaoxuan; Dowell, Alexander C; Patel, Prashant; Viney, Richard P; Foster, Michael C; Porfiri, Emilio; James, Nicholas D; Bryan, Richard T Journal: Future oncology Issue: Volume 10:Number 8(2014) Page Start: 1443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette–Guérin. (June 2014) Authors: Liu, Xiaoxuan; Dowell, Alexander C; Patel, Prashant; Viney, Richard P; Foster, Michael C; Porfiri, Emilio; James, Nicholas D; Bryan, Richard T Journal: Future oncology Issue: Volume 10:Number 8(2014) Page Start: 1443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mitotane treatment in patients with metastatic testicular Leydig cell tumor associated with severe androgen excess. Issue 3 (March 2018) Authors: Chortis, Vasileios; Johal, Nicholas J; Bancos, Irina; Evans, Matthew; Skordilis, Kassiani; Guest, Peter; Cullen, Michael H; Porfiri, Emilio; Arlt, Wiebke Journal: European journal of endocrinology Issue: Volume 178:Issue 3(2018) Page Start: K21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Spontaneous CD4+ and CD8+ T‐cell responses directed against cancer testis antigens are present in the peripheral blood of testicular cancer patients. Issue 7 (26th June 2017) Authors: Pearce, Hayden; Hutton, Paul; Chaudhri, Shalini; Porfiri, Emilio; Patel, Prashant; Viney, Richard; Moss, Paul Journal: European journal of immunology Issue: Volume 47:Issue 7(2017) Page Start: 1232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. Issue 3 (March 2023) Authors: Brown, Janet E; Royle, Kara-Louise; Gregory, Walter; Ralph, Christy; Maraveyas, Anthony; Din, Omar; Eisen, Timothy; Nathan, Paul; Powles, Tom; Griffiths, Richard; Jones, Robert; Vasudev, Naveen; Wheater, Matthew; Hamid, Abdel; Waddell, Tom; McMenemin, Rhona; Patel, Poulam; Larkin, James; Faust, G... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic target. (March 2016) Authors: Bardoli, Antonio D; Afshar, Mehran; Viney, Richard; Foster, Mike; Porfiri, Emilio; Zarkar, Anjali; Stevenson, Robert; James, Nicholas D; Bryan, Richard T; Patel, Prashant Journal: Future oncology Issue: Volume 12:Number 5(2016) Page Start: 595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗